Brief: Kiromic Biopharma Says CFO Dan Clark Notified Of His Decision To Resign
30/12/2022 21:26
Dec 30 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA INC - ON DEC 23, 2022, DAN CLARK CFO OF
CO
NOTIFIED CO OF HIS DECISION TO RESIGN FROM HIS POSITION AT CO
EFFECTIVE IMMEDIATELY
* KIROMIC BIOPHARMA INC - ON DEC 27, 2022, CO ENTERED INTO
SEPARATION AGREEMENT WITH CLARK
Source text: (https://bit.ly/3vLRIRT)
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site